Home › Fatigue › Alabama › Birmingham
Fatigue clinical trials in Birmingham, AL
5 studies for Fatigue are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Sleep Disorders Center of Alabama, Birmingham
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
RecruitingPhase 3
- Sleep Disorders Center of Alabama, Birmingham
The Fit With Us Study
Recruiting
- Wellness, Health and Research Facility, Birmingham
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Recruiting
- University of Alabama Birmingham Hospital, Birmingham
About Fatigue
Are you tired? Find out about some of the common and uncommon causes of fatigue and how to help yourself.
More about Fatigue on MedlinePlus
Fatigue trials in other cities
- Baltimore, MD8 studies
- New York City, NY7 studies
- Houston, TX7 studies
- Charlotte, NC6 studies
- Nashville, TN5 studies
- Cincinnati, OH4 studies
- Miami, FL4 studies
- Pittsburgh, PA3 studies
- League City, TX3 studies
- Atlanta, GA3 studies
- Charleston, SC3 studies
- Seattle, WA3 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.